151 related articles for article (PubMed ID: 28687332)
1. Systemic analysis of different colorectal cancer cell lines and TCGA datasets identified IGF-1R/EGFR-PPAR-CASPASE axis as important indicator for radiotherapy sensitivity.
Chen L; Zhu Z; Gao W; Jiang Q; Yu J; Fu C
Gene; 2017 Sep; 627():484-490. PubMed ID: 28687332
[TBL] [Abstract][Full Text] [Related]
2. IGF-1R depletion sensitizes colon cancer cell lines to radiotherapy.
Zong R; Chen X; Feng J; Xu S
Cancer Biomark; 2021; 32(2):199-206. PubMed ID: 34092618
[TBL] [Abstract][Full Text] [Related]
3. The clinicopathological and prognostic significances of IGF-1R and Livin expression in patients with colorectal cancer.
Zhang Z; Zhang Y; Lao S; Qiu J; Pan Z; Feng X
BMC Cancer; 2022 Aug; 22(1):855. PubMed ID: 35931997
[TBL] [Abstract][Full Text] [Related]
4. Dual silencing of type 1 insulin-like growth factor and epidermal growth factor receptors to induce apoptosis of nasopharyngeal cancer cells.
Yuan YL; Zhou XH; Song J; Qiu XP; Li J; Ye LF
J Laryngol Otol; 2008 Sep; 122(9):952-60. PubMed ID: 17908353
[TBL] [Abstract][Full Text] [Related]
5. Radioresistant laryngeal cancers upregulate type 1 IGF receptor and exhibit increased cellular dependence on IGF and EGF signalling.
Qureishi A; Rieunier G; Shah KA; Aleksic T; Winter SC; Møller H; Macaulay VM
Clin Otolaryngol; 2019 Nov; 44(6):1026-1036. PubMed ID: 31536667
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.
Raju U; Molkentine DP; Valdecanas DR; Deorukhkar A; Mason KA; Buchholz TA; Meyn RE; Ang KK; Skinner H
Cancer Med; 2015 Jan; 4(1):65-74. PubMed ID: 25355701
[TBL] [Abstract][Full Text] [Related]
7. Higher Expression of Proteins in IGF/IR Axes in Colorectal Cancer is Associated with Type 2 Diabetes Mellitus.
Ding J; Li C; Tang J; Yi C; Liu JY; Qiu M
Pathol Oncol Res; 2016 Oct; 22(4):773-9. PubMed ID: 27138191
[TBL] [Abstract][Full Text] [Related]
8. Correlation between gene expression of IGF-1R pathway markers and cetuximab benefit in metastatic colorectal cancer.
Huang F; Xu LA; Khambata-Ford S
Clin Cancer Res; 2012 Feb; 18(4):1156-66. PubMed ID: 22294722
[TBL] [Abstract][Full Text] [Related]
9. Let-7e enhances the radiosensitivity of colorectal cancer cells by directly targeting insulin-like growth factor 1 receptor.
Samadi P; Afshar S; Amini R; Najafi R; Mahdavinezhad A; Sedighi Pashaki A; Gholami MH; Saidijam M
J Cell Physiol; 2019 Jul; 234(7):10718-10725. PubMed ID: 30515804
[TBL] [Abstract][Full Text] [Related]
10. mRNA expression of IGF-1 and IGF-1R in patients with colorectal adenocarcinoma and type 2 diabetes.
Liu R; Hu LL; Sun A; Cao YJ; Tang T; Zhang XP; Zhang QH
Arch Med Res; 2014 May; 45(4):318-24. PubMed ID: 24751329
[TBL] [Abstract][Full Text] [Related]
11. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
Cunningham MP; Thomas H; Marks C; Green M; Fan Z; Modjtahedi H
Int J Oncol; 2008 Nov; 33(5):1107-13. PubMed ID: 18949375
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of EI24 confers resistance to gefitinib through IGF-1R signaling in PC9 NSCLC cells.
Choi JM; Jang JY; Choi YR; Kim HR; Cho BC; Lee HW
Lung Cancer; 2015 Nov; 90(2):175-81. PubMed ID: 26342551
[TBL] [Abstract][Full Text] [Related]
13. SiRNA-mediated IGF-1R inhibition sensitizes human colon cancer SW480 cells to radiation.
Yavari K; Taghikhani M; Maragheh MG; Mesbah-Namin SA; Babaei MH; Arfaee AJ; Madani H; Mirzaei HR
Acta Oncol; 2010; 49(1):70-5. PubMed ID: 20001499
[TBL] [Abstract][Full Text] [Related]
14. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma.
Desbois-Mouthon C; Baron A; Blivet-Van Eggelpoël MJ; Fartoux L; Venot C; Bladt F; Housset C; Rosmorduc O
Clin Cancer Res; 2009 Sep; 15(17):5445-56. PubMed ID: 19706799
[TBL] [Abstract][Full Text] [Related]
16. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
Shimizu M; Deguchi A; Hara Y; Moriwaki H; Weinstein IB
Biochem Biophys Res Commun; 2005 Sep; 334(3):947-53. PubMed ID: 16053920
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-type 1 receptor inhibitor NVP-AEW541 enhances radiosensitivity of PTEN wild-type but not PTEN-deficient human prostate cancer cells.
Isebaert SF; Swinnen JV; McBride WH; Haustermans KM
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):239-47. PubMed ID: 21816290
[TBL] [Abstract][Full Text] [Related]
18. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
[TBL] [Abstract][Full Text] [Related]
19. Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer.
Takahari D; Yamada Y; Okita NT; Honda T; Hirashima Y; Matsubara J; Takashima A; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
Oncology; 2009; 76(1):42-8. PubMed ID: 19033715
[TBL] [Abstract][Full Text] [Related]
20. Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations.
Yeo CD; Park KH; Park CK; Lee SH; Kim SJ; Yoon HK; Lee YS; Lee EJ; Lee KY; Kim TJ
Lung Cancer; 2015 Mar; 87(3):311-7. PubMed ID: 25617986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]